A new frameshift mutation in a patient with neurofibromatosis type I

Eur J Dermatol. 2023 Dec 1;33(6):697-699. doi: 10.1684/ejd.2023.4580.

Authors

Zhongzhu Hu¹, Mengling Zhou², Zilu Zeng³, He Huang¹, Meng Zhang¹, Jiahua Zou¹, Guang-Ming Xia¹, Yan Wu², Jiabin Yang⁴, Nengxing Lin²

Affiliations

¹ Huanggang Central Hospital of Yangtze University, Huanggang, China.
² Department of Dermatology, Union Hospital Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
³ Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
⁴ Department of Dermatology, the first Affiliated Hospital of Yangtze University, Jingzhou, China.

PMID: 38465558
DOI: 10.1684/ejd.2023.4580

No abstract available

MeSH terms

Frameshift Mutation
Genes, Neurofibromatosis 1
Humans
Mutation
Neurofibromatosis 1* / complications
Neurofibromatosis 1* / genetics
Neurofibromin 1 / genetics
Pedigree

Substances

Neurofibromin 1